Tdam USA Inc. decreased its holdings in Colgate-Palmolive (NYSE:CL) by 13.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 77,769 shares of the company’s stock after selling 12,531 shares during the period. Tdam USA Inc.’s holdings in Colgate-Palmolive were worth $5,330,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CL. Capital Financial Planning LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $27,000. Timber Creek Capital Management LLC boosted its holdings in Colgate-Palmolive by 247.1% in the fourth quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock worth $28,000 after acquiring an additional 336 shares in the last quarter. Parisi Gray Wealth Management lifted its holdings in shares of Colgate-Palmolive by 365.3% during the fourth quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock worth $28,000 after purchasing an additional 369 shares during the period. Portfolio Solutions LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $30,000. Finally, WP Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter worth about $34,000. Institutional investors and hedge funds own 74.63% of the company’s stock.

Shares of Colgate-Palmolive stock traded down $0.19 during trading hours on Thursday, hitting $71.34. The company’s stock had a trading volume of 78,255 shares, compared to its average volume of 3,261,580. Colgate-Palmolive has a twelve month low of $57.41 and a twelve month high of $73.10. The firm has a market cap of $61.41 billion, a PE ratio of 23.99, a price-to-earnings-growth ratio of 4.69 and a beta of 0.81. The company has a quick ratio of 0.74, a current ratio of 1.07 and a debt-to-equity ratio of 32.25.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.01. The firm had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a negative return on equity of 3,730.37% and a net margin of 15.08%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.74 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 2.41%. The ex-dividend date was Wednesday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s payout ratio is currently 57.91%.

Several brokerages recently weighed in on CL. UBS Group lifted their price target on Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Tuesday, April 23rd. Jefferies Financial Group boosted their price objective on Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a research note on Monday, April 29th. They noted that the move was a valuation call. JPMorgan Chase & Co. raised Colgate-Palmolive from an “underweight” rating to a “neutral” rating and boosted their price objective for the stock from $62.00 to $70.00 in a research note on Monday, April 29th. Finally, ValuEngine raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, May 13th. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $69.69.

In related news, VP Justin Skala sold 92,643 shares of the business’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $70.78, for a total value of $6,557,271.54. Following the sale, the vice president now owns 163,653 shares in the company, valued at approximately $11,583,359.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Ian M. Cook sold 17,750 shares of the business’s stock in a transaction on Friday, March 29th. The shares were sold at an average price of $67.37, for a total value of $1,195,817.50. Following the completion of the sale, the chief executive officer now owns 1,130,793 shares in the company, valued at approximately $76,181,524.41. The disclosure for this sale can be found here. Insiders sold a total of 335,211 shares of company stock worth $23,724,495 in the last quarter. Company insiders own 1.14% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Holdings Trimmed by Tdam USA Inc.” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://theolympiareport.com/2019/05/23/colgate-palmolive-cl-holdings-trimmed-by-tdam-usa-inc.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: Correction

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.